Pathophysiologic role of Interleukin-33/ST2 in Sjögren’s syndrome

Keyphrases

• Soluble Suppression of Tumorigenicity 2 (sST2) 100%
• Autoimmune Disease 20%
• Activated B Cells 10%
• Dry Eye 10%
• Interleukin-23 (IL-23) 10%
• Damage Progression 10%
• Decoy Receptor 10%
• NKT Cells 10%
• Systemic Damage 10%
• Activated T Cells 10%
• Proinflammatory Stimuli 10%
• Dry Mouth Syndrome 10%
• Tissue Disease 10%
• Natural Killer Cells 10%
• Epithelial Tissue 10%
• Systemic Manifestations 10%
• IL-1 Family 10%
• Nuclear Factor 10%
• Extracellular Space 10%
• Local Damage 10%

Immunology and Microbiology

• Autoimmune Disease 20%
• Extracellular Space 10%

INIS

• extracellular space 10%